OPKO Health Total Long-Term Assets 2010-2024 | OPK

OPKO Health total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
OPKO Health Annual Total Long-Term Assets
(Millions of US $)
2024 $1,538
2023 $1,702
2022 $1,773
2021 $1,577
2020 $1,950
2019 $1,985
2018 $2,133
2017 $2,241
2016 $2,283
2015 $2,345
2014 $1,125
2013 $1,149
2012 $211
2011 $130
2010 $20
2009 $24
OPKO Health Quarterly Total Long-Term Assets
(Millions of US $)
2024-12-31 $1,538
2024-09-30 $1,626
2024-06-30 $1,622
2024-03-31 $1,583
2023-12-31 $1,702
2023-09-30 $1,699
2023-06-30 $1,725
2023-03-31 $1,763
2022-12-31 $1,773
2022-09-30 $1,811
2022-06-30 $1,875
2022-03-31 $1,553
2021-12-31 $1,577
2021-09-30 $1,860
2021-06-30 $1,875
2021-03-31 $1,921
2020-12-31 $1,950
2020-09-30 $1,943
2020-06-30 $1,964
2020-03-31 $1,958
2019-12-31 $1,985
2019-09-30 $2,077
2019-06-30 $2,112
2019-03-31 $2,140
2018-12-31 $2,133
2018-09-30 $2,191
2018-06-30 $2,209
2018-03-31 $2,230
2017-12-31 $2,241
2017-09-30 $2,291
2017-06-30 $2,296
2017-03-31 $2,300
2016-12-31 $2,283
2016-09-30 $2,298
2016-06-30 $2,268
2016-03-31 $2,340
2015-12-31 $2,345
2015-09-30 $2,498
2015-06-30 $1,247
2015-03-31 $1,118
2014-12-31 $1,125
2014-09-30 $1,132
2014-06-30 $1,144
2014-03-31 $1,150
2013-12-31 $1,149
2013-09-30 $1,142
2013-06-30 $411
2013-03-31 $416
2012-12-31 $211
2012-09-30 $162
2012-06-30 $138
2012-03-31 $132
2011-12-31 $130
2011-09-30 $33
2011-06-30 $33
2011-03-31 $34
2010-12-31 $20
2010-09-30 $23
2010-06-30 $23
2010-03-31 $24
2009-12-31 $24
2009-09-30 $12
2009-06-30 $10
2009-03-31 $8
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.015B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $190.127B 83.28
Thermo Fisher Scientific (TMO) United States $153.648B 18.58
Alcon (ALC) Switzerland $47.347B 31.47
Edwards Lifesciences (EW) United States $44.043B 28.82
IDEXX Laboratories (IDXX) United States $38.097B 43.78
DexCom (DXCM) United States $31.969B 49.41
IQVIA Holdings (IQV) United States $25.777B 14.17
Mettler-Toledo (MTD) United States $22.100B 26.28
STERIS (STE) Ireland $21.856B 24.99
Waters (WAT) United States $20.170B 28.47
SONOVA HOLDING (SONVY) Switzerland $18.308B 0.00
Hologic (HOLX) United States $11.835B 12.86
Sysmex ADR (SSMXY) Japan $11.715B 0.00
Penumbra (PEN) United States $11.306B 88.74
Globus Medical (GMED) United States $9.687B 22.43
Masimo (MASI) United States $8.725B 32.29
Teleflex (TFX) United States $5.328B 8.79
Glaukos (GKOS) United States $4.983B 0.00
Integer Holdings (ITGR) United States $4.125B 21.61
TransMedics (TMDX) United States $3.159B 92.46
PROCEPT BioRobotics (PRCT) United States $2.945B 0.00
Veracyte (VCYT) United States $2.393B 43.04
LivaNova (LIVN) United Kingdom $1.917B 11.60
Elekta AB (EKTAY) Sweden $1.889B 16.98
Nihon Kohden (NHNKY) Japan $1.867B 10.21
Alphatec Holdings (ATEC) United States $1.779B 0.00
Tandem Diabetes Care (TNDM) United States $1.420B 0.00
Artivion (AORT) United States $1.171B 109.68
Pulse Biosciences (PLSE) United States $1.113B 0.00
Integra LifeSciences Holdings (IART) United States $0.991B 5.27
AxoGen (AXGN) United States $0.747B 0.00
SiBone (SIBN) United States $0.700B 0.00
IRadimed (IRMD) United States $0.649B 32.92
Mesa Laboratories (MLAB) United States $0.641B 14.01
AVANOS MEDICAL, INC (AVNS) United States $0.591B 9.24
RxSight (RXST) United States $0.567B 0.00
OrthoPediatrics (KIDS) United States $0.520B 0.00
Beta Bionics (BBNX) United States $0.492B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.471B 0.00
Treace Medical Concepts (TMCI) United States $0.464B 0.00
Delcath Systems (DCTH) United States $0.392B 0.00
NeuroPace (NPCE) United States $0.383B 0.00
ClearPoint Neuro (CLPT) United States $0.367B 0.00
AngioDynamics (ANGO) United States $0.350B 0.00
Pacific Biosciences Of California (PACB) United States $0.330B 0.00
Semler Scientific (SMLR) United States $0.318B 6.74
Neuronetics (STIM) United States $0.296B 0.00
Tactile Systems Technology (TCMD) United States $0.230B 13.94
CVRx (CVRX) United States $0.194B 0.00
Inogen (INGN) United States $0.190B 0.00
908 Devices (MASS) United States $0.190B 0.00
Alpha Tau Medical (DRTS) Israel $0.182B 0.00
Spectral Diagnostics (EDTXF) Canada $0.164B 0.00
LENSAR (LNSR) United States $0.163B 0.00
Anteris Technologies Global (AVR) Australia $0.146B 0.00
Sight Sciences (SGHT) United States $0.145B 0.00
Accuray (ARAY) United States $0.134B 0.00
Lucid Diagnostics (LUCD) United States $0.130B 0.00
KORU Medical Systems (KRMD) United States $0.126B 0.00
Atossa Genetics (ATOS) United States $0.107B 0.00
Rapid Micro Biosystems (RPID) United States $0.099B 0.00
Monogram Orthopaedics (MGRM) United States $0.098B 0.00
Microbot Medical (MBOT) United States $0.085B 0.00
EDAP TMS S.A (EDAP) France $0.080B 0.00
InspireMD (NSPR) Israel $0.077B 0.00
Sensus Healthcare (SRTS) United States $0.070B 10.60
EnVVeno Medical (NVNO) United States $0.061B 0.00
Zomedica (ZOMDF) United States $0.054B 0.00
Hyperfine (HYPR) United States $0.052B 0.00
Positron (POSC) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
Baird Medical Investment Holdings (BDMD) $0.035B 0.00
Biosig Technologies (BSGM) United States $0.035B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
NexGel (NXGL) United States $0.020B 0.00
Adagio Medical Holdings (ADGM) United States $0.019B 0.00
PAVmed (PAVM) United States $0.013B 0.00
Ekso Bionics Holdings (EKSO) United States $0.013B 0.00
Accelerate Diagnostics (AXDX) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
WORK Medical Technology Group (WOK) China $0.007B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
ReShape Lifesciences (RSLS) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.66
Longview Acquisition II (LGV) United States $0.000B 0.00